ScienceDex / Researcher record
Sarah Laun
- Capsulomics, LLC (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2024
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2024): $1.7M in linked award amounts across 2 award records · Award-linked rank #7006.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 78834188Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2024 award records by amount
NIH award records listing Sarah Laun as a PI. Multi-PI records show the full award amount for context.
- 2R42CA261376-02A1R42Contact PIAn accurate, affordable, and transferable assay for minimally invasive detection of esophageal squamous cell carcinoma (ESCC) in Africa and the United States$885Kaward amount
- 5R44DK136424-02R44Contact PIValidation and Early Commercialization of the ENVISAGE Assay, a Prognostic Test for Barrett's Esophagus$833Kaward amount
Award organization
Organizations that administered FY2024 awards listing Sarah Laun as a PI.
FY2024 award administered by Capsulomics, LLC (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardCapsulomics, LLC
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7006